Kongtal, N.; Pichitsiri, W.; Sirilak, S.; Wannakittirat, A.; Sontham, B.; Inkate, S.; Thammathiwat, T.
Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease. Viruses 2025, 17, 1216.
https://doi.org/10.3390/v17091216
AMA Style
Kongtal N, Pichitsiri W, Sirilak S, Wannakittirat A, Sontham B, Inkate S, Thammathiwat T.
Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease. Viruses. 2025; 17(9):1216.
https://doi.org/10.3390/v17091216
Chicago/Turabian Style
Kongtal, Noppakao, Watchara Pichitsiri, Supinda Sirilak, Anyarin Wannakittirat, Busakorn Sontham, Sagoontee Inkate, and Theerachai Thammathiwat.
2025. "Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease" Viruses 17, no. 9: 1216.
https://doi.org/10.3390/v17091216
APA Style
Kongtal, N., Pichitsiri, W., Sirilak, S., Wannakittirat, A., Sontham, B., Inkate, S., & Thammathiwat, T.
(2025). Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease. Viruses, 17(9), 1216.
https://doi.org/10.3390/v17091216